The risk of malignancy index (RMI) in ovarian tumors is a validated clinical tool used for risk stratification of ovarian lesions, to guide further management 1-3.
Classification
The score incorporates the patient's menopausal status (M), ultrasound features of the lesion (U), and the serum CA...